Kevin Bouiller

Kevin Bouiller is a University Professor and Hospital Practitioner (PU-PH) at the University Hospital of Besançon (CHU Besançon), specializing in Infectious Diseases. His research focuses on Staphylococcus aureus epidemiology, bone/joint infections, antibiotic resistance, Lyme borreliosis, and tick-borne diseases. He completed his master's and PhD studies on CC398 clone epidemiology and osteoarticular infections, with academic training at Upenn University.

Research Interests:

• Molecular epidemiology of Staphylococcus aureus
• Antibiotic resistance mechanisms
• Lyme borreliosis diagnosis and management
• Urinary tract infections in clinical practice
• One-Health approach to zoonotic pathogens

Publications span microbiology, clinical infectious diseases, and pandemic response. Recent work addresses SARS-CoV-2 neurological sequelae, antibiotic stewardship, and diagnostic challenges in Lyme neuroborreliosis. His studies frequently involve multicenter collaborations (e.g., DisCoVeRy trial for remdesivir efficacy in hospitalized patients).

Key contributions include:

• Guideline development for tick-borne diseases
• Analysis of CC398 human infection dynamics
• Investigations into post-COVID syndrome manifestations

Active in teaching/mentoring next-generation clinicians through trainee programs and international exchanges. Involved in clinical trials (e.g., DisCoVeRy trial) and observational studies across multiple continents.